Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1960 1
1963 2
1965 1
1967 1
1969 1
1970 1
1975 1
1976 1
1980 1
1981 1
1982 2
1984 1
1985 2
1986 3
1987 7
1988 7
1989 6
1990 5
1991 9
1992 5
1993 14
1994 18
1995 29
1996 18
1997 13
1998 13
1999 25
2000 31
2001 41
2002 50
2003 60
2004 73
2005 90
2006 104
2007 94
2008 123
2009 133
2010 132
2011 160
2012 178
2013 191
2014 213
2015 236
2016 229
2017 264
2018 306
2019 366
2020 426
2021 575
2022 596
2023 585
2024 639
2025 665
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,048 results

Results by year

Filters applied: . Clear all
Page 1
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.
Zhou C, Tang KJ, Cho BC, Liu B, Paz-Ares L, Cheng S, Kitazono S, Thiagarajan M, Goldman JW, Sabari JK, Sanborn RE, Mansfield AS, Hung JY, Boyer M, Popat S, Mourão Dias J, Felip E, Majem M, Gumus M, Kim SW, Ono A, Xie J, Bhattacharya A, Agrawal T, Shreeve SM, Knoblauch RE, Park K, Girard N; PAPILLON Investigators. Zhou C, et al. Among authors: tang kj. N Engl J Med. 2023 Nov 30;389(22):2039-2051. doi: 10.1056/NEJMoa2306441. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870976 Clinical Trial.
Succinate preserves CD8+ T cell fitness to augment antitumor immunity.
Ma K, Cheng H, Wang L, Xiao H, Liu F, Yang Y, Xiao Z, Tang K, Li S, Wang G, Ge M, Wang J, Liu X, Sun HX, Luo Z, Gu Z, Ho PC, Li G, Zhang L. Ma K, et al. Among authors: tang k. Immunity. 2025 Oct 14;58(10):2505-2523.e8. doi: 10.1016/j.immuni.2025.07.017. Epub 2025 Aug 14. Immunity. 2025. PMID: 40816269
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
Al-Lamee R, Thompson D, Dehbi HM, Sen S, Tang K, Davies J, Keeble T, Mielewczik M, Kaprielian R, Malik IS, Nijjer SS, Petraco R, Cook C, Ahmad Y, Howard J, Baker C, Sharp A, Gerber R, Talwar S, Assomull R, Mayet J, Wensel R, Collier D, Shun-Shin M, Thom SA, Davies JE, Francis DP; ORBITA investigators. Al-Lamee R, et al. Among authors: tang k. Lancet. 2018 Jan 6;391(10115):31-40. doi: 10.1016/S0140-6736(17)32714-9. Epub 2017 Nov 2. Lancet. 2018. PMID: 29103656 Free article. Clinical Trial.
A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement.
Chen Y, Yang K, Marušic A, Qaseem A, Meerpohl JJ, Flottorp S, Akl EA, Schünemann HJ, Chan ES, Falck-Ytter Y, Ahmed F, Barber S, Chen C, Zhang M, Xu B, Tian J, Song F, Shang H, Tang K, Wang Q, Norris SL; RIGHT (Reporting Items for Practice Guidelines in Healthcare) Working Group. Chen Y, et al. Among authors: tang k. Ann Intern Med. 2017 Jan 17;166(2):128-132. doi: 10.7326/M16-1565. Epub 2016 Nov 22. Ann Intern Med. 2017. PMID: 27893062
6,048 results